Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Webinar | Biosimilars: A 2020 Mid-Year Review

Thursday, July 23rd, 2020, 1:30 pm EDT

Webinar | Biosimilars: A 2020 Mid-Year Review

This webinar took place on: Thursday, July 23rd, 2020, 1:30 pm EDT

This webinar has ended.

Biologics are the fastest-growing class of therapeutic products in the United States. In 2019, the FDA approved 10 biosimilars—a new record. For pharmaceutical companies, this means that competition in the biosimilars space is heating up and creating a new sense of urgency to innovate.

In this webinar, life sciences attorneys John Adkisson, Geoff Biegler, and Jenny Shmuel provided a mid-year update on the current U.S. biosimilars space. Topics that were discussed include recent developments regarding:

  • The U.S. biosimilars market, including approvals and launches
  • FDA announcements and guidance
  • Select court cases and appellate guidance
  • Trends in IPRs

In addition, our hosts discussed how the ongoing COVID-19 pandemic has impacted U.S. biosimilars and how it could continue to do so in the future.

Click the link to download a copy of the webinar slides.

Presenters: John Adkisson, Geoff Biegler, Jenny Shmuel

Related Services
Related Industries
Related Offices